We assist you in gauging the potential danger of new entrants, monitoring the activities of existing competitors and technological developments, monitoring the health and purchasing power of suppliers and consumers, and investigating the availability of replacements and the commercial effect of a shifting market.
SGA understands your end goal and the objective for the exercise before creating a work plan for life sciences & healthcare competitive intelligence projects. Our experts speak your language and understand the threats, opportunities, challenges, and strengths of different therapeutic segments.
Our experts understand and map peers on company and product levels. We track 5,000 pharmaceutical companies and 800 key medical device companies daily and understand their launch strategies, pipelines, and roadmaps. Our AI/ML tools (proprietary) are time-tested to gather information quickly from the desired market.
Our team of data analysts is proficient in data crawling, data gathering, data cleansing, and data sorting before interpreting the insights from the most relevant information.
SGA's analyst team has been supporting clients for strategy execution by actionable insights on products, peers, and market perceptions.
Why SGA
Industry Leaders
SGA thrives by its brand promise Lifes Possible and is recognized as the trusted life sciences & healthcare business consulting and services provider company in the U.S.
12+ Languages
Multilingual capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English (U.S. & U.K.) experts (either in-house or partnerships).
Data-Driven Insights
With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.
End-To-End Solutioning
The in-house KOL capability of more than 700, along with in-house capabilities of primary market research, financial research, data analytics, engineering, IT, and ESG research and consulting, helps to present credible competitive information.
Whitepapers
Emergence of Novel Immune - Mediated Therapies
Immunotherapy has emerged as a promising treatment for cancer, with immune checkpoint inhibitors (ICIs) dominating the market. The market is projected to...
Whitepapers
Future Trends and Technological Advances in Vaccine and Disease Prevention
The introduction of vaccines for key diseases, such as meningococcal meningitis A, hepatitis E, and malaria, in recent years has helped to reduce mortality...
Whitepapers
Market Entry in 2023: Why Must You Also Look at Markets Other Than the US and Japan?
Due to dollar fluctuations and the likelihood of market recession, investors and manufacturers of medical devices and pharma are exploring new opportunities...
CASE STUDIES
We strongly believe in equal opportunity for all. Our research team consists of more females than males, i.e., 55males, and comprises PhDs, M Pharms, D Pharms, Postgraduates in Finance and Biotech, and MBAs.
